Jing Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Yao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bin Xiao
School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication - Ge Wang
Capital Medical University, Beijing Tongren Hospital, Beijing Tongren Eye Center, Beijing, China
1 shared publication Jiamin Shen
Zhejiang Zhuowang Agricultural Science and Technology Co., Ltd Hangzhou China
1 shared publicationJiangying Zeng
College of Life Sciences China Jiliang University Hangzhou China
1 shared publication- Jing Cheng
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication - Lei Tao
Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Shanghai China
1 shared publication
Latest Publications
- Open Access
- 10 February 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (5) , e14051
Comparison on chemical features and antioxidant activity of polysaccharides from Auricularia auricula by three different enzymes
To investigate and compare the chemical features and antioxidant activities of Auricularia auricula polysaccharides (AAPs), three different AAPs (AAP-M, AAP-D, and AAP-C) were prepared by mannanase, β-dextranase, and cellulase. Their chemical features were determined using high-performance liquid chromatography and infrared spectroscopy. The antioxidant properties were performed both in vitro and in vivo. Results showed that the surface morphology of the A. auricula cell wall treated with three enzymes was slightly different under scanning electron microscopy. The extraction yields of AAP-M, AAP-D, and AAP-C were 18.33% ± 1.93%, 26.42% ± 0.87%, and 17.17% ± 0.08% under optimal conditions, respectively. The monosaccharide composition, molecular weight (AAP-M, AAP-D, and AAP-C were 1.03E+03 kDa, 1.76E+03 kDa, and 1.15E+03 kDa, respectively), and antioxidant activities of the three AAPs were different. AAP-C composed of mannose, glucuronic acid, glucose, and galactose, exhibiting the remarkable ability of scavenging ABTS+, DPPH, and H2O2 (IC50 was 0.065, 0.081, and 0.293 mg/ml, respectively). Moreover, AAP-C could significantly prolonged the lifespan of Caenorhabditis elegans under oxidative stress (p < .05). The results showed that cellulase could be served as an efficient enzyme to prepare AAPs with higher antioxidant capacity. Practical applications According to the statistics of China Edible Fungi Association in 2019, the output of Auricularia auricula was accounting for 17.54% of the total output of edible fungi. AAPs account for more than 60% of the fruiting bodies and have various biological activities. Cell wall breaking is an important process of extracting AAPs which has always been the bottleneck restricting the production of AAPs. The traditional chemical acid-base method will pollute the environment, and the yield of hot water extraction is low. In contrast, the bioenzyme method widely used because of its mild conditions and environmental friendly. In this paper, three common bioenzymes which have been widely used in food industry were used to extract AAPs, and Box–Behnken design to improve the yield of AAPs. The results show that AAP-C had high yield and strong antioxidant activity. This study could provide a reference for the industrial production of AAPs.
- 10 February 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (5) , e14051
Open AccessComparison on chemical features and antioxidant activity of polysaccharides from Auricularia auricula by three different enzymes
To investigate and compare the chemical features and antioxidant activities of Auricularia auricula polysaccharides (AAPs), three different AAPs (AAP-M, AAP-D, and AAP-C) were prepared by mannanase, β-dextranase, and cellulase. Their chemical features were determined using high-performance liquid chromatography and infrared spectroscopy. The antioxidant properties were performed both in vitro and in vivo. Results showed that the surface morphology of the A. auricula cell wall treated with three enzymes was slightly different under scanning electron microscopy. The extraction yields of AAP-M, AAP-D, and AAP-C were 18.33% ± 1.93%, 26.42% ± 0.87%, and 17.17% ± 0.08% under optimal conditions, respectively. The monosaccharide composition, molecular weight (AAP-M, AAP-D, and AAP-C were 1.03E+03 kDa, 1.76E+03 kDa, and 1.15E+03 kDa, respectively), and antioxidant activities of the three AAPs were different. AAP-C composed of mannose, glucuronic acid, glucose, and galactose, exhibiting the remarkable ability of scavenging ABTS+, DPPH, and H2O2 (IC50 was 0.065, 0.081, and 0.293 mg/ml, respectively). Moreover, AAP-C could significantly prolonged the lifespan of Caenorhabditis elegans under oxidative stress (p < .05). The results showed that cellulase could be served as an efficient enzyme to prepare AAPs with higher antioxidant capacity. Practical applications According to the statistics of China Edible Fungi Association in 2019, the output of Auricularia auricula was accounting for 17.54% of the total output of edible fungi. AAPs account for more than 60% of the fruiting bodies and have various biological activities. Cell wall breaking is an important process of extracting AAPs which has always been the bottleneck restricting the production of AAPs. The traditional chemical acid-base method will pollute the environment, and the yield of hot water extraction is low. In contrast, the bioenzyme method widely used because of its mild conditions and environmental friendly. In this paper, three common bioenzymes which have been widely used in food industry were used to extract AAPs, and Box–Behnken design to improve the yield of AAPs. The results show that AAP-C had high yield and strong antioxidant activity. This study could provide a reference for the industrial production of AAPs.
- Open Access
- 27 June 2020
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 183 (1) , 213-216
Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China
Purpose The outbreak of the coronavirus disease 2019 (COVID-19) has led to interruption or delay in treatment of breast cancer patient. This commentary aims to standardize the management procedures and ensure complete or relatively complete treatment for breast cancer patients during the outbreak of COVID-19. Methods Provide detailed online diagnosis, online treatment recommendations, and face-to-face consultation suggestions. Results Breast cancer patients who are at high risk of COVID-19 are advised to consult online first. For patients who have undergone online consultation and need face-to-face consultation, try to go to the clinic alone and take necessary precautions. Medical staff should be provided with necessary training about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and knowledge of standard precautions and personal protective equipment. Conclusions This commentary focused on breast cancer patients and provided suggestions to avoid the spread of COVID-19. Some of these suggestions are also suitable for cancer patients in other lesions. We hope our suggestions are useful to oncologists in other countries and help them to overcome this challenge.
- 27 June 2020
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 183 (1) , 213-216
Open AccessStandardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China
Purpose The outbreak of the coronavirus disease 2019 (COVID-19) has led to interruption or delay in treatment of breast cancer patient. This commentary aims to standardize the management procedures and ensure complete or relatively complete treatment for breast cancer patients during the outbreak of COVID-19. Methods Provide detailed online diagnosis, online treatment recommendations, and face-to-face consultation suggestions. Results Breast cancer patients who are at high risk of COVID-19 are advised to consult online first. For patients who have undergone online consultation and need face-to-face consultation, try to go to the clinic alone and take necessary precautions. Medical staff should be provided with necessary training about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and knowledge of standard precautions and personal protective equipment. Conclusions This commentary focused on breast cancer patients and provided suggestions to avoid the spread of COVID-19. Some of these suggestions are also suitable for cancer patients in other lesions. We hope our suggestions are useful to oncologists in other countries and help them to overcome this challenge.
- 1 July 2014
- Published by Elsevier in Toxicology Letters
- Vol. 228 (1) , 1-12
LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G2/M phase arrest and cell apoptosis in MCF-7 human breast cancer cells in vitro and in vivo
- 1 July 2014
- Published by Elsevier in Toxicology Letters
- Vol. 228 (1) , 1-12
LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G2/M phase arrest and cell apoptosis in MCF-7 human breast cancer cells in vitro and in vivo